Pliant Therapeutics
PLRX
81 hedge funds and large institutions have $893M invested in Pliant Therapeutics in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
17% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 23
7% more funds holding
Funds holding: 76 → 81 (+5)
0.44% less ownership
Funds ownership: 85.95% → 85.51% (-0.44%)
26% less capital invested
Capital invested by funds: $1.21B → $893M (-$314M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $189K
Top Buyers
Top Sellers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$8.54M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.02M |
| 3 |
BlackRock
New York
|
-$3.65M |
| 4 |
Bank of New York Mellon
New York
|
-$3.63M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.58M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SIC
76
Salem Investment Counselors
Winston Salem,
North Carolina
| $2K | – | – | – |
|
77
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $2K | +$2.37K | +76 | New |
|
|
NFG
78
Next Financial Group
Houston,
Texas
| $1K | – | – | – |
|
|
CA
79
Clearstead Advisors
Cleveland,
Ohio
| $1K | +$1.25K | +40 | New |
|
|
AIG
80
American International Group
New York
| $393 | -$16.1K | -518 | -4% |
|
81
Nisa Investment Advisors
St. Louis,
Missouri
| $41 | +$43.6K | +1,400 | New |
|
82
California Public Employees Retirement System
Sacramento,
California
| – | -$661K | -16,800 | Closed |
|
|
DCM
83
Dupont Capital Management
Wilmington,
Delaware
| – | -$545K | -13,850 | Closed |
|
84
Principal Financial Group
Des Moines,
Iowa
| – | -$340K | -8,635 | Closed |
|
|
HA
85
HC Advisors
Sandy Springs,
Georgia
| – | -$216K | -5,493 | Closed |
|
86
SG Americas Securities
New York
| – | -$179K | -4,553 | Closed |
|
|
NFSG
87
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$39K | -1,000 | Closed |
|
88
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$32K | -868 | Closed |
|
PLRX Hedge Fund Activity: Q2 2021 in Review
81 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Pliant Therapeutics (PLRX) for Q2 2021, worth a combined $893M — down 26% from $1.21B a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new PLRX positions and 7 closed out — a net gain of 5 holders — while 27 added to existing stakes and 23 trimmed.
The largest buyer was Vanguard Group, adding an estimated $5.26M. The largest seller was Farallon Capital Management, cutting an estimated $8.54M.
- 81 institutional investors held Pliant Therapeutics (PLRX) as of Q2 2021, up from 76 in Q1 2021.
- Funds reported $893M of Pliant Therapeutics stock for Q2 2021, down 26% quarter-over-quarter.
- 12 funds opened new Pliant Therapeutics positions in Q2 2021 and 7 closed out, a net change of +5 holders.
- The largest Pliant Therapeutics buyer in Q2 2021 was Vanguard Group, an estimated $5.26M added.
- The largest Pliant Therapeutics seller in Q2 2021 was Farallon Capital Management, an estimated $8.54M sold.
Based on aggregated 13F filings for Q2 2021.